Diagnosis and treatment progress of malignant mesothelioma of the tunica vaginalis testis
10.3969/j.issn.1009-8291.2023.02.020
- VernacularTitle:睾丸鞘膜恶性间皮瘤的诊疗进展
- Author:
Hao ZHANG
1
;
Wanxiang ZHENG
1
;
Lei ZHANG
1
;
Jianlin YUAN
1
Author Information
1. Department of Urology, Xijing Hospital of the Air Force Medical University, Xi’an 710032, China
- Publication Type:Journal Article
- Keywords:
testis;
mesothelioma;
asbestos;
orchiectomy;
chemoradiotherapy;
scrotal mass
- From:
Journal of Modern Urology
2023;28(2):171-175
- CountryChina
- Language:Chinese
-
Abstract:
Malignant mesothelioma of the tunica vaginalis testis (MMTVT) is a rare tumor. At present, there are still many disputes in its epidemiology, pathogenesis, selection of diagnostic methods, treatment and prognosis. Asbestos exposure, ionizing radiation and chromosome abnormalities are the risk factors of MMTVT. Immunohistochemistry, ultrasonography and electron microscope can be used for the diagnosis and aggressive surgery is the main treatment method. The development of endoscopic surgery, multi-disciplinary treatment (MDT), tumor targeted therapy and immunotherapy will bring more benefits to MMTVT patients.
